Fierce New Product Planning Summit 2022

Tony Russell is currently Director, Commercial Development in Immunology and Inflammation at Pfizer with a focus on early research programs in fibrosis and immune tolerance. With over 20 years of industry experience, Tony has worked across multiple facets in the biopharmaceutical... Read More →

Tim Johnson is currently the Head of New Product Planning and Competitive Intelligence at Blueprint Medicines.  He has 22-years of experience across a range of transformative therapeutics (i.e., small molecules, targeted protein degradation, recombinant proteins, and cell & gene... Read More →

Jeff is an associate director of corporate development and portfolio strategy at Agenus, a clinical stage immuno-oncology company, where he works cross-functionally to support/lead corporate and business development, portfolio strategy and analytics, and early commercial planning... Read More →

Charles Pak is Executive Director of New Product Planning at Alkermes with responsibility across oncology and neuroscience.  He has extensive new product planning experience at various companies, including Syros Pharmaceuticals, Immunogen, Eisai, and Vertex Pharmaceuticals.  He... Read More →